In The News
USA Today | February 22, 2017
“There will be a lot of major developments when it comes to this research,” Kevin Hrusovsky
Alzforum | April 20, 2017
Tau pathology is linked with neurodegeneration in multiple tauopathies, and efforts are underway to vanquish this tangle-forming protein with anti-tau antibodies.
GenomeWeb| July 18, 2017
NEW YORK (GenomeWeb) – A team of investigators from Quanterix, Destina Genomics, and the University of Edinburgh have developed a new approach for the amplification-free detection of microRNA-122, a biomarker used for diagnosing liver toxicity.
CLP Magazine | September 26, 2017
Quanterix Corp, Lexington, Mass, is expanding its single molecule array, or Simoa, portfolio to include the new Quanterix SR-Plex benchtop instrument.
Enjoyed discussing the future of cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.
David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
June 3, 2010
Read the article at www.technologyreview.com
September 3, 2013
Bio-IT World Read the article at www.bio-itworld.com
May 25, 2014
Newsweek Read the article at www.newsweek.com
January 7, 2015
BioProcess Online and Clinical Leader Read the article at www.bioprocessonline.com or at